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The penetration of an optically active ofloxacin isomer [(-)-ofloxacin] into human neutrophils and different
tissue culture cells (HEp-2, McCoy, MDCK, and Vero) was studied and compared with that of ofloxacin by a
fluorometric assay. The cellular-to-extracellular-concentration ratios (CIE) of (-)-ofloxacin were always higher
than 6, significantly greater than those of ofloxacin at extracellular concentrations of 5 and 10 mg/liter. The
penetration of (-)-ofloxacin and ofloxacin was doubled when neutrophils were stimulated by phorbol myristate
acetate but not affected after ingestion of opsonized Staphylococcus aureus. The CIE ratios of (-)-ofloxacin and
ofloxacin for different tissue culture epithelial cells and fibroblasts were lower than those of neutrophils but still
higher than 2. Both compounds produced a significant reduction in viable intraphagocytic S. aureus during 3
h of exposure to antimicrobial agents. We conclude that (-)-ofloxacin appears to reach higher intracellular
concentrations than ofloxacin, remaining active inside the neutrophils.
Ofloxacin (OFLX) is a quinolone compound that shows
high activity against a variety of gram-positive and gram-
negative bacteria (17). By using high-performance liquid
chromatography, two optically active OFLX isomers have
been prepared: (+)-OFLX and (-)-OFLX (6). The latter
isomer inhibited the supercoiling activity of gyrase from
Micrococcus luteus 7.4 times more effectively than did the
(+)-isomer (7). Moreover, the in vitro activity of (-)-OFLX
against a variety of gram-positive and gram-negative bacteria
was 8 to 128 times higher than that of (+)-OFLX and twice
as high as that of racemic OFLX (6).
The intracellular penetration and activity of antimicrobial
agents can be an important factor in the treatment of
infections caused by intracellular facultative or obligate
pathogens. Most studies on the ability of antimicrobial
agents to penetrate into cells have utilized phagocytic cells,
and only a few studies have evaluated the penetration into
other types of cells, such as epithelial cells (1, 2). There is,
however, strong evidence that some enteroinvasive bacteria
such as enteroinvasive Escherichia coli survive in epithelial
cells despite high external aminoglycoside concentrations
because of the low intracellular penetration rate of these
antimicrobial agents (8).
We have previously reported that OFLX penetrates into
human polymorphonuclear leukocytes (PMNs) by an active
mechanism and remains active intracellularly against Staph-
ylococcus aureus (13). Since the antimicrobial activity of
OFLX seems to be mediated mainly by (-)-OFLX, it would
be important to study whether this isomer can be concen-
trated into phagocytes and other eucaryotic cells.
The purpose of this study is to evaluate the intracellular
penetration of this optically active OFLX isomer, (-)-
OFLX, into human PMNs and different tissue culture cells
compared with that of OFLX. The intracellular activity in
PMNs of both compounds against S. aureus is also assessed.
MATERIALS AND METHODS
Isolation of PMNs. PMNs were recovered from heparin-
ized venous blood of healthy donors and were purified by
previously described methods (16). PMN preparations were
* Corresponding author.
97% pure. Final cell suspensions were adjusted to 5 x 106
PMNs per ml in Hanks balanced salt solution. PMNs were
95% viable by trypan blue exclusion.
Tissue culture cells. HEp-2, McCoy, MDCK, and Vero
cells (Flow Laboratories, Irvine, United Kingdom) were
grown in minimal essential medium (Flow) supplemented
with 1 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid; Flow) and containing 10% fetal calf
serum (Flow) without antibiotics. For each experiment cells
were detached from tissue culture bottles with trypsin-
EDTA (Flow) and suspended ir Hanks balanced salt solu-
tion at a concentration of 5 x 106 cells per ml.
Antimicrobial agent uptake by cells. A previously de-
scribed fluorometric assay to measure quinolone uptake by
human PMNs was used (13). The optically active ofloxacin
isomer (-)-OFLX was kindly supplied by Daiichi Seiyaku
Co., Ltd. (Tokyo, Japan), and OFLX was supplied by
Hoescht (Federal Republic of Germany). In these experi-
ments PMNs or tissue culture cells were incubated in Hanks
balanced salt solution containing different concentrations of
the antimicrobial agent (2, 5, and 10 mg/liter). After different
incubation times (1.5, 20, and 30 min) at 37°C, cells were
separated from extracellular solution by centrifugation
through a water-impermeable silicone-oil barrier in a micro-
centrifuge tube (9). The entire cell pellet, obtained by cutting
off the portion of the microfuge tube containing the pellet,
was placed in 2 ml of 0.1 M glycine-HCl buffer (pH 3.0) and
agitated vigorously in a vortex shaker. Incubation for 2 h at
room temperature was sufficient to release fully intracellular
antimicrobial agent. The samples were centrifuged for 5 min
at 5,600 x g, and the amount of antimicrobial agent was
determined by fluorescence emission of the supernatants
with a Kontron SFM 25 fluorescence spectrophotometer
(Kontron, Switzerland). The fluorescence excitation and
emission maxima of OFLX and (-)-OFLX in 0.1 M glycine-
HCl (pH 3.0) were 292 and 496 nm, respectively. Controls
without antimicrobial agents were always used to determine
the background fluorescence.
The intracellular water space was measured by using
tritiated water and the extracellular marker [14C]polyethy-
lene glycol (1.4 mCi/g; New England Nuclear Corp., Boston,
Mass.). The cells were incubated with these radiolabeled
277
 on A



























compounds for 2 min at 37°C, and then cells were separated
from extracellular fluid by velocity gradient centrifugation as
described above and counted in a liquid scintillation counter.
The total water content of the cell pellet was corrected for
trapped extracellular water, i.e., polyethylene glycol space,
to obtain the intracellular water space. From the values
obtained from this procedure, cell-associated antimicrobial
agent concentrations were calculated and expressed as a
ratio of the cellular concentration to extracellular concentra-
tion (CIE) (9).
In a series of experiments, OFLX and (-)-OFLX (extra-
cellular concentration, 5 mg/liter) uptake by human PMNs
was measured after stimulation of the cells with 200 nM
either phorbol myristate acetate (PMA; Sigma Chemical
Co., St. Louis, Mo.) or S. aureus ATCC 25923 opsonized in
5% pooled human serum (15 min, 37°C) at a 10/1 ratio of
bacteria to PMNs. PMA or opsonized bacteria were added to
the PMN suspensions at the same time as the antimicrobial
agents, and the uptake was measured as described above.
Since the measurement of OFLX and (-)-OFLX is indirect
and dependent upon fluorescence, controls were always
performed to evaluate the effect of stimuli on the fluores-
cence of the antimicrobial agents in cell-free systems.
Intracelular activity of antimicrobial agents. To evaluate
the intracellular activity of antimicrobial agents, a previously
described method was used (15). Briefly, 0.1 ml of opsonized
bacterial suspension (5 x 107 CFU/ml) and 0.1 ml of PMNs
(5 x 106 PMNs per ml) were combined in a series of
polypropylene biovials (Beckman Instruments, Inc., Fuller-
ton, Calif.) and incubated in a shaker (250 rpm) for 60 min at
370C. After incubation, extracellular bacteria were removed
by differential centrifugation. Cells were then suspended in
0.2 ml of RPMI medium (GIBCO, United Kingdom). At this
time (designated time zero) the different antimicrobial agents
were added, and the vials were incubated in a shaker (250
rpm) at 370C. Vials were removed at time zero (control) and
after 3 h of incubation (control and samples with antimicro-
bial agents). Cells were lysed in distilled water, and samples
were diluted and pour plated in agar. Colonies were counted
after 24 h of incubation at 370C. The data were expressed as
percentages of surviving staphylococci compared with con-

















FIG. 1. OFLX (C1) and (-)-OFLX (O) uptake by human PMNs
at different extracellular concentrations (n = 6). Incubations were
done for 20 min. For the data from concentrations of 5 and 10
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FIG. 2. OFLX (0) and (-)-OFLX (A) uptake by human PMNs
at different times (n = 4). The extracellular concentration was 5
mg/liter.
to determining bacterial survival, morphologic studies were
also routinely performed at time zero and after 3 h of
incubation to evaluate the disposition of bacteria (cell asso-
ciated or extracellular). Samples of 50 ,ul were removed from
biovials and deposited on glass slides. After staining with
Wright stain, samples were examined by light microscopy.
All assays were performed in duplicate with PMNs from five
different donors.
Statistical analysis of data. Data were expressed as the
means standard deviations. Differences among groups
were compared by analysis of variance with the Bonferroni
method (18), used to assess statistical significance at P s
0.05.
RESULTS
Uptake of antimicrobial agents by PMNS. Figure 1 shows
the CIE ratios of OFLX and (-)-OFLX incubated with
human PMNs at different extracellular concentrations. Both
OFLX and (-)-OFLX showed high CIE ratios, being signif-
icantly higher for the latter at extracellular concentrations of
S and 10 mg/liter. The penetration or cell association of
OFLX occurred slightly more rapidly than did that of
(-)-OFLX (Fig. 2).
The stimulation of PMNs by a membrane activator (PMA)
enhanced the intracellular penetration of OFLX and (-)-
OFLX 2.4 and 1.5 times, respectively (Table 1). The incu-
bation of PMNs with opsonized S. aureus ATCC 25923,
however, did not modify the uptake of either compound.
TABLE 1. Effect of the incubation of human PMNs with either
opsonized S. aureus ATCC 25923 or PMA on the uptake




None (control) 6.0 ± 1.3 8.3 ± 1.7
Opsonized S. aureus 5.2 ± 1.1 7.0 ± 1.6
PMA (200 nM) 14.4 ± 2.3" 13.0 ± 2.3"
a Incubations were done for 20 min. The extracellular concentration of
OFLX or (-)-OFLX was 5 mg/liter.
b p < 0.05 compared with the control.
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OFLOXACIN ISOMER UPTAKE BY HUMAN NEUTROPHILS
TABLE 2. OFLX and (-)-OFLX uptake by human PMNs and
different tissue culture cells (n =4)
Antimicro- CIE ratio
bial agent PMN HEp-2 McCoy MDCK Vero
OFLX 5.8 ± 1.2 2.1 ± 0.2 3.9 ± 1.1 2.1 ± 0.9 3.4 ± 1.2
(-)-OFLX 8.2 1.7b 2.8 ± 0.6 4.7 ± 1.3 1.9 ± 0.9 2.4 ± 0.6
a Incubations were done for 20 min. The extracellular concentration of
OFLX or (-)-OFLX was 5 mg/liter.
b p < 0.05 compared with value for OFLX.
Uptake of antimicrobial agents by tissue culture cells. The
CIE ratios of OFLX and (-)-OFLX incubated with three
tissue culture epithelial cells from different origins (HEp-2,
McCoy, and MDCK) and one tissue culture fibroblast cell
line (Vero) for 20 min at 37°C are shown in Table 2. The CIE
ratios of OFLX and (-)-OFLX were 2 to 3 times lower than
those observed with PMNs, and there were no significant
differences between the two compounds.
Intracellular activities of antimicrobial agents. The intrac-
ellular activities of different concentrations of OFLX and
(-)-OFLX against S. aureus ATCC 25923 were evaluated in
a 3-h assay (Table 3). At all of the concentrations evaluated,
(-)-OFLX produced a significant reduction of the survival of
S. aureus in PMNs, similar to that produced by OFLX.
DISCUSSION
(-)-OFLX is an optically active OFLX isomer that shows
higher in vitro activity than (+)-OFLX and the racemic
compound OFLX against different microorganisms (6, 7).
The purpose of this study was to evaluate whether this
increased activity was accompanied by a higher intracellular
penetration and activity than those of OFLX. The (-)-
OFLX uptake by human PMNs was significantly higher than
that of OFLX at extracellular concentrations of 5 and 10
mg/liter. This difference was not observed at a lower con-
centration (2 mg/liter). Nevertheless, both compounds
reached high intracellular concentrations in these phago-
cytes, as has been described for other quinolones with
different methodology (3, 10).
The penetration of (-)-OFLX and OFLX was not affected
when PMNs were incubated with opsonized S. aureus. This
has been described for other antimicrobial agents such as
erythromycin, rifampin, and gentamicin (5). However, the
TABLE 3. Effect of OFLX and (-)-OFLX on the survival of
S. aureus ATCC 25923 within human PMNs (n = 5)
Antimicrobial agent and % Survival of
concn (mg/liter) S. aureus at 3 h
No agent 45.5 ± 5.2
OFLX
0.5 20.9 ± 3. la
2 17.6 ± 3.0O
5 15.0 ± 2.7a
10 5.8 ± 1.4a
(-)-OFLX
0.5 17.8 ± 3.2a
2 15.5 ± 3. la
5 12.2 ± 2.6a
10 9.1 ± 2.1la
a P < 0.05 compared with the control.
penetration of other antimicrobial agents, such as clindamy-
cin, has been shown to increase after phagocytosis of S.
aureus (5).
The stimulation of PMN membranes by PMA, however,
doubled the uptake of both compounds by human PMNs,
pointing out that the penetration of (-)-OFLX into PMNs
could be mediated by an active mechanism, as has been
demonstrated for ofloxacin (13), since PMA activates the
NADPH oxidase system via protein kinase C (11). To study
the penetration of these antimicrobial agents into other
eucaryotic cells, we used a tissue culture cell model. The
penetration of both compounds into tissue culture epithelial
cells and fibroblasts was significantly lower than that ob-
served in PMNs but still reached intracellular concentrations
that were at least double the extracellular concentrations.
The use of this model offers an interesting insight into the
penetration of antibacterial substances into cells and may
have relevance to human infections produced by microor-
ganisms that. are able to survive and even multiply within
epithelial cells.
Contrasts between phagocyte antimicrobial agent uptake
and intracellular activity have been described for a few
antimicrobial agents (5, 15). In our study, (-)-OFLX showed
a good intracellular penetration into and activity in PMNs
against S. aureus. The intracellular antimicrobial activity of
this isomer was similar to that observed for the racemic
compound and similar to those described for other quino-
lones against different bacteria (4,12, 14).
In summary, (-)-OFLX, an optically active OFLX iso-
mer, penetrated into human PMN, reaching concentrations
higher than -those reached by OFLX and remaining active
intracellularly. This compound also showed a high penetra-
tion into tissue culture epithelial cells and fibroblasts. The
high antimicrobial activity of this compound, higher even
than that of the racemic compound OFLX, added to the
properties observed in this study, could justify additional
studies to evaluate the possible clinical relevance of these
findings.
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